Kenneth Mitchell, PA
Physician Assistant · Woodbury, MNNPI 1922096379
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Endo Pharmaceuticals Inc. at 38.2% of the total. Reporting peaked in 2022 at $29,970 and has fallen 73.1% since, to $8,059 in 2025. Among physician assistant clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 289 payments — averaging $301.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endo Pharmaceuticals Inc.$33K
- Antares Pharma, Inc.$30K
- Tolmar Pharmaceuticals, Inc.$10K
- Endo USA, Inc.$6K
- Coloplast$4K
- Boston Scientific$2K
- plus $2K from 19 others
What the payments were for
- Consulting fees$14,24016%
- Speaking & faculty fees$42,38549%
- Travel & lodging$18,91322%
- Food & beverage$11,56513%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endo Pharmaceuticals Inc. | 100 | $33,273 |
| Antares Pharma, Inc. | 44 | $29,813 |
| Tolmar Pharmaceuticals, Inc. | 17 | $9,617 |
| Endo USA, Inc. | 30 | $6,338 |
| Coloplast | 29 | $4,406 |
| Boston Scientific | 22 | $1,667 |
| Myovant Sciences Inc. | 14 | $371 |
| Tolmar, Inc. | 5 | $324 |
| Halozyme Inc | 5 | $263 |
| Axonics, Inc. | 1 | $165 |
| Olympus America Inc. | 2 | $123 |
| Valencia Technologies Corporation | 2 | $116 |
| Palette Life Sciences, Inc. | 2 | $99 |
| Amgen | 1 | $86 |
| Bayer | 2 | $64 |
| Johnson & Johnson | 2 | $64 |
| Astellas Pharma US Inc | 1 | $60 |
| Acerus Pharmaceuticals Corporation | 1 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Millicent US Inc | 2 | $40 |
| Profound Medical Corp. | 1 | $30 |
| AbbVie | 1 | $30 |
| Merck | 1 | $29 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Dendreon Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIAFLEX$37,331
- XYOSTED$28,740
- TLANDO$13,804
- ELIGARD$9,139
- Biatain Ag Non-Adhesive$2,066
- TITAN$1,986
- GENERAL ERECTILE DYSFUNCTION$339
- FENSOLVI$300
- AMS 700 CXR RTE KIT$296
- Bulkamid$165
- VIRTUE$158
- AVEED$129
- ORGOVYX$119
- iTIND System$105
- GENERAL KIDNEY STONE DISEASE$100
How this compares
$87,103 in reported general payments places this provider in the 95th percentile of 3,121 physician assistant providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XyostedTestosterone Enanthate | 12 | $9,962 |
| MyrbetriqMirabegron | 12 | $6,841 |
| Cabergoline | 12 | $1,351 |
| Testosterone Cypionate | 16 | $661 |
| Tamsulosin Hcl | 33 | $399 |
| Anastrozole | 41 | $353 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Antares Pharma, Inc.Xyosted | $29,813 | $9,96212 claims |
| Astellas Pharma US IncMyrbetriq | $60 | $6,84112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,121 physician assistant providers in Minnesota.
Other physician assistant in Woodbury
- Jeffrey SandquistWoodbury$26K
- Michael JensonWoodbury$7K
- Mitchell MacbethWoodbury$5K
- Sara RobeckBloomington$274K
- Natalie IkemanEdina$170K
- Adam HetzBlaine$156K
- Sarah SchettleRochester$150K
- John IsenbergMaple Grove$92K
- Jennifer SutherlandMinneapolis$65K
- George FroehleMinneapolis$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.